PNAA
BIIB icon

Pictet North America Advisors’s Biogen BIIB Stock Holding History

Pictet North America Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,700
Closed -$629K – 159
2019
Q3 		$629K Hold
2,700
– – 0.09% 102
2019
Q2 		$631K Buy
+2,700
New +$623K 0.09% 102

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pictet North America Advisors's BIIB Position: Q4 2019 in Review

Pictet North America Advisors sold out of Biogen (BIIB) in Q4 2019, closing a stake of 2,700 shares — an estimated $629K sold.

Pictet North America Advisors first reported a position in BIIB in Q2 2019 and held it in 2 quarters. The position peaked at $631K in Q2 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Pictet North America Advisors reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Pictet North America Advisors sold 2,700 Biogen shares in Q4 2019, an estimated $629K.
  • Pictet North America Advisors first reported a position in Biogen in Q2 2019 and held it in 2 quarters.
  • Pictet North America Advisors's Biogen position peaked at $631K in Q2 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Pictet North America Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.